Peter H. Seeberger
Peter H. Seeberger studied chemistry and biochemistry in Erlangen (Germany) and Boulder (USA). After completing his PhD and performing research at the Sloan-Kettering Cancer Center Research in New York he built an independent research program at MIT where he was promoted to Firmenich Associate Professor of Chemistry with tenure after just four years. After six years as Professor at the Swiss Federal Institute of Technology (ETH) Zurich he assumed positions as Director at the Max-Planck Institute for Colloids and Surfaces in Potsdam and Professor at the Free University of Berlin. In addition he serves as Affiliate Professor at the Sanford-Burnham Institute for Medical Research (La Jolla, USA) and honorary Professor at the University of Potsdam.
Professor Seeberger’s research on the chemistry and biology of carbohydrates, continuous flow chemistry and automation of chemistry, carbohydrate vaccine development and a broad range of topics from engineering to immunology has been documented in over 360 peer-reviewed journal articles, two books, more than 30 patents, over 150 published abstracts and more than 630 invited lectures. This work was recognized with more than 25 international awards from the US (e.g. Arthur C. Cope Young Scholar Award, Horace B. Isbell Award, Claude S. Hudson Award from the American Chemical Society), Germany (e.g. Körber Prize for European Sciences), Holland (Havinga Medal), Israel (Honorary Lifetime Member Israel Chemical Society), Japan (Yoshimasa Hirata Gold Medal), Switzerland (“The 100 Most Important Swiss”) and international organizations (Whistler Award 2012, International Carbohydrate Society). In 2013 he was elected to the Berlin-Brandenburg Academy of Sciences.
Peter H. Seeberger served the scientific community in many functions. He greatly supports the idea of open access publishing as the Editor-in-Chief of the Beilstein Journal of Organic Chemistry, was the Editor of the Journal of Carbohydrate Chemistry and serves on the editorial advisory boards of many other journals.
Through his work in the area of neglected diseases, Peter Seeberger has become involved in philanthropic causes. He is a co-founder of the Tesfa-Ilg “Hope for Africa” Foundation that aims at improving health care in Ethiopia that recently helped to build a bed-net factory and established an IT training center.
The research in the Seeberger laboratory has given rise to several spin-off companies in the USA and Germany.